Fibrinogen function indexes are potential biomarkers of diabetic peripheral neuropathy
Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and th...
Saved in:
Published in | Diabetology and metabolic syndrome Vol. 14; no. 1; pp. 13 - 7 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
18.01.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored.
This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls.
Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669).
The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN. |
---|---|
AbstractList | Abstract Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. Subjects and methods This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Results Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051–0.124], P < 0.001; odds ratio 1.131 [1.063–1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r = − 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). Conclusions The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN. Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. Subjects and methods This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Results Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051–0.124], P < 0.001; odds ratio 1.131 [1.063–1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r = − 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). Conclusions The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN. Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle [alpha], reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. Subjects and methods This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Results Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle [alpha] levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle [alpha] with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle [alpha] levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle [alpha] levels was 60[degrees], with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). Conclusions The k value and angle [alpha] are closely associated with DPN. The levels of the k value and angle [alpha] may be helpful in the early diagnosis of DPN. Keywords: Diabetic peripheral neuropathy, Fibrinogen, k value, Angle [alpha], Diagnosis This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle [alpha] levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle [alpha] with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle [alpha] levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle [alpha] levels was 60[degrees], with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). The k value and angle [alpha] are closely associated with DPN. The levels of the k value and angle [alpha] may be helpful in the early diagnosis of DPN. Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored. This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls. Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669). The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN. Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored.BACKGROUND AND OBJECTIVESResearch suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function has not been reported. Here, the k value and angle α, reflecting the plasma Fib function, were used to analyse its correlation with DPN, and their potential as biological indicators for diagnosing DPN was explored.This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls.SUBJECTS AND METHODSThis prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic neuropathy (161 cases), diabetes with asymptomatic neuropathy (132 cases) and diabetes with no neuropathy (268 cases) groups. Meanwhile, 160 healthy unrelated subjects were recruited as controls.Fib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669).RESULTSFib levels increased slightly in diabetic subjects with neuropathy compared with those without. The angle α levels increased slightly in subjects with asymptomatic DPN compared with those with no neuropathy and increased greatly in subjects with symptomatic DPN compared with those without. The k value levels slightly decreased in subjects with asymptomatic DPN compared with those with no neuropathy and greatly decreased in subjects with symptomatic DPN compared with those without. The association of the k value and angle α with diabetic neuropathy was independent of the hyperglycaemic state and other potential confounders (odds ratio 0.080 [0.051-0.124], P < 0.001; odds ratio 1.131 [1.063-1.204], P < 0.001). The k value and angle α levels were closely correlated with neuropathy stage (r = - 0.686, P < 0.000; r = 0.314, P < 0.001). The optimal cut-off point for k value levels to distinguish patients with diabetic neuropathy from those without was 1.8 min, with a sensitivity of 73.7% and a specificity of 83.2% (AUC = 0.873). The optimal cut-off point for angle α levels was 60°, with a sensitivity of 41.0% and a specificity of 95.6% (AUC = 0.669).The k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN.CONCLUSIONSThe k value and angle α are closely associated with DPN. The levels of the k value and angle α may be helpful in the early diagnosis of DPN. |
ArticleNumber | 13 |
Audience | Academic |
Author | Lin, Xiahong Wu, Xiaohong Zhang, Jinying Zhuang, Yong Chen, Xiaoyu |
Author_xml | – sequence: 1 givenname: Yong surname: Zhuang fullname: Zhuang, Yong – sequence: 2 givenname: Xiahong orcidid: 0000-0001-8445-818X surname: Lin fullname: Lin, Xiahong – sequence: 3 givenname: Xiaoyu surname: Chen fullname: Chen, Xiaoyu – sequence: 4 givenname: Xiaohong surname: Wu fullname: Wu, Xiaohong – sequence: 5 givenname: Jinying surname: Zhang fullname: Zhang, Jinying |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35042559$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1DAUhiNURC_wAixQJCTEJsWO49sGqaooVKrEBthajnMy8ZCxg50g-vac6ZQyUyGUhaPj7_zn4v-0OAoxQFG8pOScUiXeZcqIVhWpaUWIlLKST4oTKrmquNbiaO__uDjNeU2IkFw2z4pjxklTc65Pim9Xvk0-xBWEsl-Cm30MpQ8d_IJc2gTlFGcIs7dj2fq4sek7pFzGvuy8bWH2rpwg-WmAhESAJcXJzsPt8-Jpb8cML-7Ps-Lr1Ycvl5-qm88fry8vbirHdTNXoq2FVZQprgUFx62jRHPdMkKow4AQrpE9I0x2UgreONm1ulUtU0BtJwk7K653ul20azMljx3emmi9uQvEtDI2YZcjmBpqVjsunG5pg2W0Rfm-a7TC0rq1qPV-pzUt7QY6h2PjUAeihzfBD2YVfxolRSNlgwJv7wVS_LFAns3GZwfjaAPEJZta1LTmUlOO6OtH6DouKeCqthQ2xyVRf6mVxQF86CPWdVtRcyE0k4SKhiF1_g8Kvw423qFleo_xg4Q3ewkD2HEechyX7dvnQ_DV_kYeVvHHPgjUO8ClmHOC_gGhxGw9anYeNehRc-dRIzFJPUpyfrbb4ti3H_-X-ht8v-kD |
CitedBy_id | crossref_primary_10_1007_s12640_023_00657_0 crossref_primary_10_7759_cureus_74977 crossref_primary_10_4274_jcrpe_galenos_2021_2021_0148 crossref_primary_10_1186_s10020_023_00698_3 crossref_primary_10_3390_ph17091139 crossref_primary_10_1186_s12902_022_01185_2 crossref_primary_10_3389_fendo_2022_930271 crossref_primary_10_1007_s12020_024_03689_4 crossref_primary_10_1111_cns_70040 crossref_primary_10_3389_fendo_2025_1501323 crossref_primary_10_3389_fendo_2023_1143067 |
Cites_doi | 10.1097/00001721-199509000-00011 10.1016/j.ejphar.2013.07.017 10.1016/j.neulet.2014.11.020 10.2337/db20182-1 10.1001/jama.2013.168118 10.1016/j.dsx.2015.10.011 10.1056/NEJMoa0908292 10.1007/s11892-003-0006-0 10.1371/journal.pone.0153389 10.1055/s-2004-830524 10.1097/WNP.0000000000000522 10.1016/j.diabres.2018.02.023 10.1016/j.diabres.2016.01.002 10.4172/2155-6156 10.1097/MD.0000000000001783 10.1530/EJE-14-0381 10.1016/j.vph.2017.03.005 10.1159/000081919 10.1016/S2213-8587(19)30081-6 10.1056/NEJMc1004671 10.1016/j.actbio.2016.09.024 10.2337/dc13-0590 10.1016/S1056-8727(00)00132-X 10.1016/j.neucli.2018.03.001 10.1002/ana.410080608 10.2310/7750.2013.WOUND3 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
DBID | AAYXX CITATION NPM 3V. 7QP 7TS 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s13098-021-00777-7 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Physical Education Index ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1758-5996 |
EndPage | 7 |
ExternalDocumentID | oai_doaj_org_article_2e232c56c9b141099ac66fd49861e9ba PMC8764774 A693701643 35042559 10_1186_s13098_021_00777_7 |
Genre | Journal Article |
GeographicLocations | Germany |
GeographicLocations_xml | – name: Germany |
GrantInformation_xml | – fundername: Startup Fund for scientific research, Fujian Medical University grantid: 2020QH1118 – fundername: ; grantid: 2020QH1118 |
GroupedDBID | --- 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION DIK E3Z EBD EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RBZ RNS ROL RPM RSV SMD SOJ TUS U2A UKHRP -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 NPM PMFND 7QP 7TS 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c594t-6b26a81385961ec5ac10959b3001c1ec66c47f3037d77654c7db9b8b38e1ad703 |
IEDL.DBID | DOA |
ISSN | 1758-5996 |
IngestDate | Wed Aug 27 01:25:17 EDT 2025 Thu Aug 21 13:57:40 EDT 2025 Thu Jul 10 23:15:01 EDT 2025 Mon Jun 30 03:52:45 EDT 2025 Tue Jun 17 21:39:48 EDT 2025 Tue Jun 10 20:23:08 EDT 2025 Thu May 22 21:23:32 EDT 2025 Thu Jan 02 22:55:04 EST 2025 Tue Jul 01 01:26:45 EDT 2025 Thu Apr 24 23:08:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Diagnosis Diabetic peripheral neuropathy Angle α k value Fibrinogen |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c594t-6b26a81385961ec5ac10959b3001c1ec66c47f3037d77654c7db9b8b38e1ad703 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-8445-818X |
OpenAccessLink | https://doaj.org/article/2e232c56c9b141099ac66fd49861e9ba |
PMID | 35042559 |
PQID | 2620995708 |
PQPubID | 54993 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2e232c56c9b141099ac66fd49861e9ba pubmedcentral_primary_oai_pubmedcentral_nih_gov_8764774 proquest_miscellaneous_2621257915 proquest_journals_2620995708 gale_infotracmisc_A693701643 gale_infotracacademiconefile_A693701643 gale_healthsolutions_A693701643 pubmed_primary_35042559 crossref_primary_10_1186_s13098_021_00777_7 crossref_citationtrail_10_1186_s13098_021_00777_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-01-18 |
PublicationDateYYYYMMDD | 2022-01-18 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-18 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Diabetology and metabolic syndrome |
PublicationTitleAlternate | Diabetol Metab Syndr |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | C Hile (777_CR11) 2003; 3 Z Zhao (777_CR19) 2016; 115 Y Xu (777_CR1) 2013; 310 C Erem (777_CR26) 2005; 14 J Li (777_CR7) 2013; 36 MN Thabit (777_CR5) 2018; 35 T Kwok (777_CR28) 2013; 17 PJ Dyck (777_CR18) 1980; 8 ME Carr (777_CR15) 2001; 15 M Iftikhar (777_CR27) 2014; 26 AJM Boulton (777_CR4) 2018 NC Kwai (777_CR23) 2016; 11 CP Yang (777_CR22) 2015; 94 W Yang (777_CR2) 2010; 362 ME Carr Jr (777_CR25) 1995; 6 V Fonseca (777_CR21) 2006; 29 D Selvarajah (777_CR6) 2019; 7 H Yuan (777_CR20) 2012; S5 NH Cho (777_CR3) 2018; 138 PS Van Dam (777_CR16) 2013; 719 T Behl (777_CR24) 2017; 92 G Hussain (777_CR10) 2016; 10 F Gholami (777_CR12) 2018; 48 W Yang (777_CR17) 2010; 362 T Zhu (777_CR9) 2015; 12 E Coban (777_CR14) 2005; 113 JY Hsieh (777_CR13) 2017; 47 Y Hu (777_CR8) 2014; 171 |
References_xml | – volume: 6 start-page: 567 issue: 6 year: 1995 ident: 777_CR25 publication-title: Blood Coagul Fibrinolysis doi: 10.1097/00001721-199509000-00011 – volume: 719 start-page: 180 issue: 13 year: 2013 ident: 777_CR16 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2013.07.017 – volume: 12 start-page: 28 issue: 585 year: 2015 ident: 777_CR9 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2014.11.020 – year: 2018 ident: 777_CR4 publication-title: Arlington American Diabetes Association doi: 10.2337/db20182-1 – volume: 310 start-page: 948 issue: 9 year: 2013 ident: 777_CR1 publication-title: JAMA doi: 10.1001/jama.2013.168118 – volume: 10 start-page: S135 issue: 1 year: 2016 ident: 777_CR10 publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2015.10.011 – volume: 362 start-page: 1090 issue: 12 year: 2010 ident: 777_CR2 publication-title: N Engl J Med doi: 10.1056/NEJMoa0908292 – volume: 3 start-page: 446 issue: 6 year: 2003 ident: 777_CR11 publication-title: Curr Diab Rep doi: 10.1007/s11892-003-0006-0 – volume: 11 issue: 4 year: 2016 ident: 777_CR23 publication-title: PLoS ONE doi: 10.1371/journal.pone.0153389 – volume: 113 start-page: 35 issue: 1 year: 2005 ident: 777_CR14 publication-title: Exp Clin Endocrinol Diabetes doi: 10.1055/s-2004-830524 – volume: 35 start-page: 474 issue: 6 year: 2018 ident: 777_CR5 publication-title: J Clin Neurophysiol doi: 10.1097/WNP.0000000000000522 – volume: 29 start-page: S3 issue: Suppl 1 year: 2006 ident: 777_CR21 publication-title: Diabetes Care. – volume: 138 start-page: 271 year: 2018 ident: 777_CR3 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2018.02.023 – volume: 115 start-page: 50 issue: 1 year: 2016 ident: 777_CR19 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2016.01.002 – volume: S5 start-page: 007 year: 2012 ident: 777_CR20 publication-title: J Diabetes Metab doi: 10.4172/2155-6156 – volume: 94 issue: 42 year: 2015 ident: 777_CR22 publication-title: Medicine doi: 10.1097/MD.0000000000001783 – volume: 171 start-page: 641 issue: 5 year: 2014 ident: 777_CR8 publication-title: Eur J Endocrinol doi: 10.1530/EJE-14-0381 – volume: 92 start-page: 1 year: 2017 ident: 777_CR24 publication-title: Vascul Pharmacol doi: 10.1016/j.vph.2017.03.005 – volume: 14 start-page: 22 issue: 1 year: 2005 ident: 777_CR26 publication-title: Med Princ Pract doi: 10.1159/000081919 – volume: 7 start-page: 938 issue: 12 year: 2019 ident: 777_CR6 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(19)30081-6 – volume: 362 start-page: 2425 issue: 25 year: 2010 ident: 777_CR17 publication-title: N Engl J Med doi: 10.1056/NEJMc1004671 – volume: 47 start-page: 14 year: 2017 ident: 777_CR13 publication-title: Acta Biomater doi: 10.1016/j.actbio.2016.09.024 – volume: 36 start-page: 3405 issue: 11 year: 2013 ident: 777_CR7 publication-title: Diabetes Care doi: 10.2337/dc13-0590 – volume: 15 start-page: 44 issue: 1 year: 2001 ident: 777_CR15 publication-title: Diab Complic doi: 10.1016/S1056-8727(00)00132-X – volume: 26 start-page: 584 issue: 4 year: 2014 ident: 777_CR27 publication-title: J Ayub Med Coll Abbottabad – volume: 48 start-page: 195 issue: 4 year: 2018 ident: 777_CR12 publication-title: Neurophysiol Clin doi: 10.1016/j.neucli.2018.03.001 – volume: 8 start-page: 590 issue: 6 year: 1980 ident: 777_CR18 publication-title: Ann Neurol doi: 10.1002/ana.410080608 – volume: 17 start-page: S1 issue: Suppl 1 year: 2013 ident: 777_CR28 publication-title: J Cutan Med Surg doi: 10.2310/7750.2013.WOUND3 |
SSID | ssj0067574 |
Score | 2.3199801 |
Snippet | Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its correlation with Fib function... Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although its... This prospective observational clinical study enrolled 561 type 2 diabetes mellitus (T2DM) patients, who were divided into the diabetes with symptomatic... Abstract Background and objectives Research suggests that diabetic peripheral neuropathy (DPN) is related to plasma fibrinogen (Fib) concentrations, although... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 13 |
SubjectTerms | Angle α Asymptomatic Biomarkers Blood pressure Cholesterol Creatinine Diabetes Diabetes mellitus (non-insulin dependent) Diabetic neuropathies Diabetic neuropathy Diabetic peripheral neuropathy Diabetic retinopathy Diagnosis Disease Fibrin Fibrinogen Glucose Growth factors Hospitals k value Liver Medical diagnosis Metabolism Patients Peripheral neuropathy Plasma Statistical analysis Type 2 diabetes Vitamin deficiency |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k3aAkFC4oCi5uHnCRXEqkIqJ4r2ZtkTBypVybLZHvj3zDje0Aip13i8Wo_nZXvmG8beOaErcLoqXAlQcKl5oXWAogmuA9068C296J5_k2cX_OtarNOF25jSKvc2MRrqdgC6Iz8h4HRjhCr1x83vgrpG0etqaqFxl90j6DJK6VLr-cCFsbDi-0IZLU9GtNdUUFbjAbpUShVq4YwiZv__lvmGa1qmTd7wQ6tH7GEKIPPTaccfszuhf8Lun6cn8qfsx4qS-PsBBSMnp0WMzyMmYhhztw35ZthRhhD-BpXeU3bOdsyHLp9uYS8hJ-zjCDZwlUe0S2pa_OcZu1h9-f75rEjNEwoQhu8K6WuJe9BoYWQVQDio6MrPN-iXAD9ICVx16MBUq5QUHFTrjde-0aFyLdqB5-ygH_rwkuVeBCHaui1xhIOunRKAqi4CTq-7rs5YteeihYQsTg0urmw8YWhpJ85b5LyNnLcqYx_mOZsJV-NW6k-0OTMlYWLHD8P2p00qZuuA0SEICcZT8qoxDhfZtdxoZIDxLmNvaGvtVGA6a7Y9lRiiEdJYk7H3kYJ0GxcALpUoIBsIJWtBebygRJ2E5fBefGyyCaP9J8EZezsP00zKc-vDcB1pMOJUphIZezFJ27zoRpCBFSZjaiGHC64sR_rLXxExHF0exzj_8Pa_dcQe1FTcUVZFpY_ZwW57HV5hyLXzr6Ne_QUU1iow priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9VAEF9qBfEifptaNYLgQaIvyX4eRKr4KMLz5JPelt3JphYeSc17hfa_d2bzQYPFk9fd2cDOx85sduY3jL1xQufgdJ65BUDGpeaZ1gGyMrgadOXAV_Siu_ouj9f824k42WNju6OBgdsbr3bUT2rdbd5f_r76hAb_MRq8lh-2eA5ToViBF-OFUipTt9ht9EyKDHXFp1cFjI0VHwtnblw3c04Rw__vk_qaq5qnUV7zS8v77N4QUKZHvQY8YHuhecjurIYn80fs55KS-psWFSUlJ0aCSCNGYtimrgvpebujjCH8BpXiU7ZOt03bOu3_yp5BSljIEXxgk0b0S2pifPWYrZdff3w5zoZmChkIw3eZ9IVEmZRaGJkHEA5y-gXoS_RTgANSAlc1OjRVKSUFB1V547UvdchdhefCE7bftE14xlIvghBVUS1whoMunBKApi8CLi_qukhYPnLRwoA0Tg0vNjbeOLS0Pectct5GzluVsHfTmvMeZ-Of1J9JOBMlYWTHgbY7tYPJ2SJgtAhCgvGUzGqMw03WFTcaGWC8S9grEq3tC04nS7dHEkM2Qh4rE_Y2UpD24QbADSULyAZCzZpRHs4o0UZhPj2qjx1V3FIrAGOEWuiEvZ6maSXlvTWhvYg0GIEqk4uEPe21bdp0KejAFSZhaqaHM67MZ5qzXxFBHF0gx7j_4H-w8Tm7W1BJyCLPcn3I9nfdRXiBgdrOv4zW9wcfhTo3 priority: 102 providerName: Scholars Portal |
Title | Fibrinogen function indexes are potential biomarkers of diabetic peripheral neuropathy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35042559 https://www.proquest.com/docview/2620995708 https://www.proquest.com/docview/2621257915 https://pubmed.ncbi.nlm.nih.gov/PMC8764774 https://doaj.org/article/2e232c56c9b141099ac66fd49861e9ba |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9RAFB-0gngRv02t6wiCBwndJPN5bKVrEbaIWNnbMPMywUJJyu724H_f9ybZsEHQi5ccMm9C8sv7muS93zD2wUtTgDdF7ucAuVBG5MZEyKvoGzC1h1DTH93lhTq_FF9XcrW31RfVhPX0wD1wx2XEmA9SgQ1UkmitB6WaWlijimhDSo0w5u0WU70PxixYi12LjFHHG_TU1EpW4tJ5rrXO9SQMJbb-P33yXlCaFkzuRaDFE_Z4SB35SX_LT9m92D5jD5fDz_Hn7OeCyvfbDlWCU7giyHliQ4wb7teR33Rbqg3Ca1DTPdXlrDe8a3j__fUKOLEeJ5qBa554Lmm74t8v2OXi7Mfn83zYNiEHacU2V6FUiH5lpEWIQHoo6GNfqDAiAZ5QCoRuMHTpWmslBeg62GBCZWLha_QAL9lB27XxNeNBRinrsp7jiABTei0BjVxGnF42TZmxYoeig4FTnLa2uHZpbWGU65F3iLxLyDudsU_jnJueUeOv0qf0ckZJYsNOJ1BH3KAj7l86krF39Gpd31o62rQ7UZicEcdYlbGPSYKsGh8A_NCcgDAQP9ZE8mgiidYI0-Gd-rjBG2wckf5bK_XcZOz9OEwzqcKtjd1tksFcU9tCZuxVr23jQ1eSXKu0GdMTPZygMh1pr34lrnAMdgIz_MP_AeMb9qik5o95kRfmiB1s17fxLaZk2zBj9_VKz9iD07OLb99nyRbx-GVV4HEpzB3WRzaz |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8ChQYJxAFF3Tz8OiDUQldb2l0h1KLeXMdxaKUq2e5uhfqn-I3MOMnSCKm3XuOxFY_HM2N75huAd4bJ2BoZR2ZobZRxmUVSOhulzpRWFsbmBb3oTqZ8fJR9O2bHa_Cny4WhsMpOJ3pFXdSW7si3CDhdKSaG8vPsIqKqUfS62pXQaMRi3139xiPb4tPeV1zf90ky2j38Mo7aqgKRZSpbRjxPOP5cKpnisbPM2JjuwvIUFbbFD5zbTJSo2UUhBGeZFUWucpmn0sWmwA2C496B9SzFo8wA1nd2p99_dLofvW-Rdak5km8t0EJQCluCR_ahECISPfPnqwT8bwuuGcN-oOY1yzd6CA9alzXcbmTsEay56jHcnbSP8k_g54jSBqoaRTEkM0lLHXoURrcIzdyFs3pJMUk4BiX7UzzQfBHWZdjc-57ZkNCWPbzBeejxNalM8tVTOLoVxj6DQVVX7gWEOXOMFUkxxJbMysQIZlG5MIfdk7JMAog7LmrbYplTSY1z7c80kuuG8xo5rz3ntQjg46rPrEHyuJF6hxZnRUko3P5DPf-l202tE4f-qGXcqpzCZZUyOMmyyJREBqjcBLBJS6ublNaVLtHbHJ1CwjZLA_jgKUib4ASsaZMikA2Ey9Wj3OhRohaw_eZOfHSrhRb6354J4O2qmXpSZF3l6ktPgz6uUDEL4HkjbatJp4xUOlMBiJ4c9rjSb6nOTj1GORrZDE8WL2_-rU24Nz6cHOiDven-K7ifUGrJMI5iuQGD5fzSvUaHb5m_aXdZCCe3vbH_AubfZyE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fibrinogen+function+indexes+are+potential+biomarkers+of+diabetic+peripheral+neuropathy&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Yong+Zhuang&rft.au=Xiahong+Lin&rft.au=Xiaoyu+Chen&rft.au=Xiaohong+Wu&rft.date=2022-01-18&rft.pub=BMC&rft.eissn=1758-5996&rft.volume=14&rft.issue=1&rft.spage=1&rft.epage=7&rft_id=info:doi/10.1186%2Fs13098-021-00777-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_2e232c56c9b141099ac66fd49861e9ba |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon |